Goal 3: Advance Translational Research

A Collaboration Market Place for Industry and Academia to advance Translational Medicine

There is a vast amount of data regarding specific gene and protein targets, especially in the post genomics era with many well validated targets, and even more "strong candidates". Drug companies have libraries of compounds that could be good inhibitors/enhancers for these new targets but lack an internal program, IP of the target, or a sufficiently large market to initiate risky and expensive drug screens, let alone Phase 1 and 2 trials. NHLBI could operate a grant based "Market Place" to facilitate Private-public collaborations.

Tags (Keywords associated with the idea)


27 net votes
45 up votes
18 down votes
Idea No. 388